Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
This guide covers the fees that can affect the Dividend Aristocrats ETF, from management to trading costs, with tips for evaluating their impact.
11,478 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Bitcoin faces renewed selling pressure this week, with analysts signaling a bitcoin (btc) price warning that a deeper...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...
A growing share of older investors are moving away from high-yield bond funds toward short-term Treasury ETFs in sear...
Cybersecurity shares jumped after inflation data cooled, lifting risk sentiment. CrowdStrike climbs 11% and Palo Alto...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...
SLV has surged about 132% over the past year as inflation fears persist. But the 0.50% annual fee and a 28% tax on co...
A blockchain-focused stock fund is up about 11% year-to-date while Bitcoin slides about 29%, signaling a shift in how...
Bitcoin's recent surge has sparked talk of a new bull leg. Yet Wintermute's warning — wintermute cautions 'relief ral...
China’s DeepSeek AI forecasts upside for XRP, Bitcoin and Ethereum through 2026, citing improving on-chain data and a...
A hypothetical whistleblower raises questions about how government narratives can influence markets. This article exp...
Two leveraged gold bets, DGP and UGL, jump with gold but carry different risk profiles. This analysis explains the st...